Erector Spinae Plane Versus Transversus Abdominis Plane Block for Pain Control

NCT ID: NCT06292832

Last Updated: 2024-03-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

68 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-10

Study Completion Date

2024-09-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The present stratified randomized study aimed to compare the analgesic efficacy and safety profile of ESPB and TAPB used for postoperative pain management in obese and morbidly obese women undergoing CS.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The present stratified randomized study aimed to compare the analgesic efficacy and safety profile of ESPB and TAPB used for postoperative pain management in obese and morbidly obese women undergoing CS. The present study will include ASA I-II women scheduled for elective CS under intrathecal anesthesia. Patients will be excluded if they had local infection, bleeding disorder or known allergy to any of the study medications. This study defines obesity as body mass index (BMI) ≥ 30 kg/m2 while morbid obesity is defined as BMI ≥ 40 kg/m2 assessed in the last pre-pregnancy visit (Sagi-Dain et al., 2021). The study will include normal weight women (n=86), obese women (n=86) and morbidly obese women (n=86).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cesarean Section Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Obese Spinae Plane Block

Spinae Plane Block for pain control

Group Type ACTIVE_COMPARATOR

Ultrasound-guided pain block

Intervention Type PROCEDURE

Ultrasound-guided pain block after cesarean section

Ultrasound Machine

Intervention Type DEVICE

Ultrasound machine used to guide the nerve block.

Obese Transversus Abdominis Plane Block

Transversus Abdominis Plane Block for pain control.

Group Type ACTIVE_COMPARATOR

Ultrasound-guided pain block

Intervention Type PROCEDURE

Ultrasound-guided pain block after cesarean section

Ultrasound Machine

Intervention Type DEVICE

Ultrasound machine used to guide the nerve block.

Morbidly Obese Spinae Plane Block

Spinae Plane Block for pain control

Group Type ACTIVE_COMPARATOR

Ultrasound-guided pain block

Intervention Type PROCEDURE

Ultrasound-guided pain block after cesarean section

Ultrasound Machine

Intervention Type DEVICE

Ultrasound machine used to guide the nerve block.

Morbidly Obese Transversus Abdominis Plane Block

Transversus Abdominis Plane Block for pain control.

Group Type ACTIVE_COMPARATOR

Ultrasound-guided pain block

Intervention Type PROCEDURE

Ultrasound-guided pain block after cesarean section

Ultrasound Machine

Intervention Type DEVICE

Ultrasound machine used to guide the nerve block.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ultrasound-guided pain block

Ultrasound-guided pain block after cesarean section

Intervention Type PROCEDURE

Ultrasound Machine

Ultrasound machine used to guide the nerve block.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ASA I-II women scheduled for elective CS under intrathecal anesthesia.

Exclusion Criteria

* had local infection, bleeding disorder or known allergy to any of the study medications
Minimum Eligible Age

20 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Al-Azhar University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Warda Demerdash Khalifa Ali

Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Warda Ali

Role: PRINCIPAL_INVESTIGATOR

Al-Azhar University, Assiut, Egypt

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Al-Azhar University

Asyut, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Warda Ali

Role: CONTACT

00109939124

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Warda Ali

Role: primary

010300020456

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MSR/AZAST/AIP029/22/222/8/2023

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.